{
  "meta": {
    "id": "test11",
    "title": "Neuromuscular Blocking Drugs",
    "category": "Subject Wise / Mixed"
  },
  "questions": [
    {
      "text": "What is the mechanism of action of non-depolarizing neuromuscular blockers like the curare group of muscle relaxants?",
      "options": [
        {
          "label": "A",
          "text": "Persistent Depolarization at Neuromuscular Junction",
          "correct": false
        },
        {
          "label": "B",
          "text": "Persistent Depolarization at the Ach Receptors",
          "correct": false
        },
        {
          "label": "C",
          "text": "Competitively Blocking the binding of ACh to its Receptors",
          "correct": true
        },
        {
          "label": "D",
          "text": "Inhibiting the Calcium Channel on the Neuronal Membrane",
          "correct": false
        }
      ],
      "correct_answer": "C. Competitively Blocking the binding of ACh to its Receptors",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. Competitively Blocking the binding of ACh to its Receptors</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Persistent Depolarization at Neuromuscular Junction : is not the correct mechanism . Non-depolarizing neuromuscular blockers do not cause persistent depolarization ; instead, they block the depolarization initiated by acetylcholine .</li><li>\u2022 Option A.</li><li>\u2022 Persistent Depolarization at Neuromuscular Junction</li><li>\u2022 not the correct mechanism</li><li>\u2022 do not</li><li>\u2022 persistent depolarization</li><li>\u2022 block</li><li>\u2022 depolarization initiated by acetylcholine</li><li>\u2022 Option B. Persistent Depolarization at the ACh Receptors : is not accurate . These drugs do not cause persistent depolarization ; they prevent depolarization by inhibiting ACh binding.</li><li>\u2022 Option B.</li><li>\u2022 Persistent Depolarization at the ACh Receptors</li><li>\u2022 not accurate</li><li>\u2022 do not cause persistent depolarization</li><li>\u2022 prevent depolarization</li><li>\u2022 Option D . Inhibiting the Calcium Channel on the Neuronal Membrane : is not the mechanism of action for non-depolarizing neuromuscular blockers . These drugs do not directly affect calcium channels .</li><li>\u2022 Option D</li><li>\u2022 Inhibiting the Calcium Channel on the Neuronal Membrane</li><li>\u2022 not</li><li>\u2022 mechanism of action</li><li>\u2022 non-depolarizing neuromuscular blockers</li><li>\u2022 do not directly</li><li>\u2022 affect calcium channels</li><li>\u2022 Educational objective:</li><li>\u2022 Educational objective:</li><li>\u2022 Non-depolarizing neuromuscular blockers competitively block the binding of acetylcholine to its receptors , leading to muscle relaxation and paralysis , and are essential in anesthesia and critical care for various medical procedures .</li><li>\u2022 competitively block</li><li>\u2022 binding</li><li>\u2022 acetylcholine</li><li>\u2022 receptors</li><li>\u2022 leading</li><li>\u2022 muscle relaxation</li><li>\u2022 paralysis</li><li>\u2022 essential</li><li>\u2022 anesthesia</li><li>\u2022 critical care</li><li>\u2022 medical procedures</li><li>\u2022 Ref : Millers anesthesia 8th edition page 959-965</li><li>\u2022 Ref : Millers anesthesia 8th edition page 959-965</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "3df453e6",
      "audio": ""
    },
    {
      "text": "Identify the drug which does not belong to the curare group of muscle relaxants?",
      "options": [
        {
          "label": "A",
          "text": "Pancuronium",
          "correct": false
        },
        {
          "label": "B",
          "text": "D-Tubocurarine",
          "correct": false
        },
        {
          "label": "C",
          "text": "Succinylcholine",
          "correct": true
        },
        {
          "label": "D",
          "text": "Vecuronium",
          "correct": false
        }
      ],
      "correct_answer": "C. Succinylcholine",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. Succinylcholine</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A . Pancuronium : Pancuronium is a non-depolarizing neuromuscular blocking agent and belongs to the curare group of muscle relaxants . It acts by competitively blocking the binding of acetylcholine to its receptors at the neuromuscular junction .</li><li>\u2022 Option A</li><li>\u2022 Pancuronium</li><li>\u2022 non-depolarizing neuromuscular blocking agent</li><li>\u2022 belongs</li><li>\u2022 curare group</li><li>\u2022 muscle relaxants</li><li>\u2022 competitively blocking</li><li>\u2022 binding</li><li>\u2022 acetylcholine to its receptors</li><li>\u2022 neuromuscular junction</li><li>\u2022 Option B . D-Tubocurarine : D-Tubocurarine is the prototypical non-depolarizing neuromuscular blocking agent and is a classic member of the curare group . It exerts its effects by blocking nicotinic acetylcholine receptors .</li><li>\u2022 Option B</li><li>\u2022 D-Tubocurarine</li><li>\u2022 prototypical non-depolarizing neuromuscular blocking agent</li><li>\u2022 classic member</li><li>\u2022 curare group</li><li>\u2022 exerts</li><li>\u2022 blocking nicotinic acetylcholine receptors</li><li>\u2022 Option D . Vecuronium : Vecuronium is a non-depolarizing neuromuscular blocking agent and is part of the curare group . It acts as a competitive antagonist at the neuromuscular junction .</li><li>\u2022 Option D</li><li>\u2022 Vecuronium</li><li>\u2022 non-depolarizing neuromuscular blocking agent</li><li>\u2022 curare group</li><li>\u2022 competitive antagonist</li><li>\u2022 neuromuscular junction</li><li>\u2022 Educational objective :</li><li>\u2022 Educational objective</li><li>\u2022 Suxamethonium or succinyl choline is a depolarizing muscle relaxant . It does not belong to the curare group.</li><li>\u2022 depolarizing muscle relaxant</li><li>\u2022 Ref : Morgan and Mikhail\u2019s clinical anaesthesiology 5 th edition pg 210</li><li>\u2022 Ref :</li><li>\u2022 Morgan and Mikhail\u2019s clinical anaesthesiology 5 th edition pg 210</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "f7b3e81f",
      "audio": ""
    },
    {
      "text": "A 40-year-old patient is posted for emergency exploratory laparotomy; the anaesthetist wants to perform rapid sequence intubation. What would be the muscle relaxant of choice for rapid sequence intubation?",
      "options": [
        {
          "label": "A",
          "text": "Atracurium",
          "correct": false
        },
        {
          "label": "B",
          "text": "Cisatracurium",
          "correct": false
        },
        {
          "label": "C",
          "text": "Rocuronium",
          "correct": false
        },
        {
          "label": "D",
          "text": "Succinylcholine",
          "correct": true
        }
      ],
      "correct_answer": "D. Succinylcholine",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D. Succinylcholine</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Muscle relaxant of choice for rapid sequence intubation is Succinylcholine is due to:</li><li>\u2022 Muscle relaxant</li><li>\u2022 choice</li><li>\u2022 rapid sequence intubation</li><li>\u2022 Rapid onset of action Shortest acting muscle relaxant</li><li>\u2022 Rapid onset of action</li><li>\u2022 Rapid onset</li><li>\u2022 action</li><li>\u2022 Shortest acting muscle relaxant</li><li>\u2022 Shortest acting muscle relaxant</li><li>\u2022 In case of contraindication to succinylcholine \u2013 drug of choice for RSI \u2013 Rocuronium</li><li>\u2022 In case of contraindication to succinylcholine \u2013 drug of choice for RSI \u2013 Rocuronium</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 The muscle relaxant of choice for rapid sequence intubation is Succinylcholine</li><li>\u27a4 The muscle relaxant of choice for rapid sequence intubation is Succinylcholine</li><li>\u27a4 Ref : Millers Anesthesia 8th ed pg 1020</li><li>\u27a4 Ref :</li><li>\u27a4 Millers Anesthesia 8th ed pg 1020</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "12864f47",
      "audio": ""
    },
    {
      "text": "A 40-year-old patient is posted for emergency exploratory laparotomy; the anaesthetist wants to perform rapid sequence intubation. Succinylcholine can be used in all of the following patients except?",
      "options": [
        {
          "label": "A",
          "text": "Burns Patient",
          "correct": false
        },
        {
          "label": "B",
          "text": "Spinal Cord Injury",
          "correct": false
        },
        {
          "label": "C",
          "text": "Guillain Barre Syndrome",
          "correct": false
        },
        {
          "label": "D",
          "text": "All of the above",
          "correct": true
        }
      ],
      "correct_answer": "D. All of the above",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D. All of the above</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A . Burns Patient : Burns can lead to an increased release of potassium from damaged cells , potentially causing Hyperkalemia . Succinylcholine, a depolarizing neuromuscular blocker , can further elevate potassium levels and should be avoided in burn patients to prevent life-threatening Hyperkalemia .</li><li>\u2022 Option A</li><li>\u2022 Burns Patient</li><li>\u2022 lead</li><li>\u2022 increased release</li><li>\u2022 potassium</li><li>\u2022 damaged cells</li><li>\u2022 potentially causing Hyperkalemia</li><li>\u2022 depolarizing neuromuscular blocker</li><li>\u2022 elevate potassium levels</li><li>\u2022 avoided</li><li>\u2022 burn patients</li><li>\u2022 prevent life-threatening Hyperkalemia</li><li>\u2022 Option B . Spinal Cord Injury : Patients with spinal cord injuries may have altered regulation of potassium due to impaired neural control . Succinylcholine administration can lead to uncontrolled potassium release and severe Hyperkalemia in these patients.</li><li>\u2022 Option B</li><li>\u2022 Spinal Cord Injury</li><li>\u2022 may</li><li>\u2022 altered regulation of potassium</li><li>\u2022 impaired neural control</li><li>\u2022 uncontrolled potassium release</li><li>\u2022 severe Hyperkalemia</li><li>\u2022 Option C . Guillain-Barre Syndrome : Guillain-Barre syndrome is a neurological disorder that can affect the peripheral nervous system . Patients with this condition may already have altered neuromuscular transmission , and succinylcholine can exacerbate the risk of Hyperkalemia .</li><li>\u2022 Option C</li><li>\u2022 Guillain-Barre Syndrome</li><li>\u2022 neurological disorder</li><li>\u2022 affect</li><li>\u2022 peripheral nervous system</li><li>\u2022 already</li><li>\u2022 altered neuromuscular transmission</li><li>\u2022 succinylcholine</li><li>\u2022 exacerbate</li><li>\u2022 risk of Hyperkalemia</li><li>\u2022 Educational objective :</li><li>\u2022 Educational objective</li><li>\u2022 Succinylcholine in certain conditions can cause life-threatening Hyperkalemia . These conditions are:</li><li>\u2022 cause life-threatening Hyperkalemia</li><li>\u2022 Burns Spinal cord injury Old stroke Tetanus Prolonged immobilization Myopathies Guillain-Barre syndrome Malignant hyperthermia history</li><li>\u2022 Burns</li><li>\u2022 Spinal cord injury</li><li>\u2022 Old stroke</li><li>\u2022 Tetanus</li><li>\u2022 Prolonged immobilization</li><li>\u2022 Myopathies</li><li>\u2022 Guillain-Barre syndrome</li><li>\u2022 Malignant hyperthermia history</li><li>\u2022 Note - Pre-existing Hyperkalemia conditions like A) Chronic Renal Failure B) Head Injury C) Advanced liver failure/sepsis due to decreases concentration of Pseudocholine-esterase D) Duchene Muscle dystrophy/Dystrophia myotonica E) Avoid in the new-born (extra-junctional receptors which increase the K+ level).</li><li>\u2022 Note - Pre-existing Hyperkalemia</li><li>\u2022 Ref : Morgan and Mikhail\u2019s clinical anaesthesiology 5 th edition pg 210</li><li>\u2022 Ref : Morgan and Mikhail\u2019s clinical anaesthesiology 5 th edition pg 210</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "0ceb703f",
      "audio": ""
    },
    {
      "text": "The enzyme that degrades succinylcholine is called as:",
      "options": [
        {
          "label": "A",
          "text": "Butyrylcholinesterase",
          "correct": true
        },
        {
          "label": "B",
          "text": "Succinyl cholinesterase",
          "correct": false
        },
        {
          "label": "C",
          "text": "Acetylcholinesterase",
          "correct": false
        },
        {
          "label": "D",
          "text": "Anti-acetylcholinesterase",
          "correct": false
        }
      ],
      "correct_answer": "A. Butyrylcholinesterase",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A. Butyrylcholinesterase</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Butyrylcholinesterase/ Pseudocholinesterase is the enzyme which degrades succinyl choline . It is synthesized in the liver and found in the plasma .</li><li>\u2022 Butyrylcholinesterase/ Pseudocholinesterase</li><li>\u2022 enzyme</li><li>\u2022 degrades succinyl choline</li><li>\u2022 synthesized</li><li>\u2022 liver</li><li>\u2022 found in the plasma</li><li>\u2022 Enzyme activity is reduced in:</li><li>\u2022 Liver disease Pregnancy Malnutrition Old age Use of drugs like - oral contraceptives, monoamine oxidase inhibitors</li><li>\u2022 Liver disease</li><li>\u2022 Pregnancy</li><li>\u2022 Malnutrition</li><li>\u2022 Old age</li><li>\u2022 Use of drugs like - oral contraceptives, monoamine oxidase inhibitors</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 Butyrylcholinesterase/ Pseudocholinesterase is the enzyme that degrades succinyl choline.</li><li>\u27a4 Butyrylcholinesterase/ Pseudocholinesterase is the enzyme that degrades succinyl choline.</li><li>\u27a4 Ref : Millers Anesthesia 8 th edition pg 961</li><li>\u27a4 Ref :</li><li>\u27a4 Millers Anesthesia 8 th edition pg 961</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "ba7441b0",
      "audio": ""
    },
    {
      "text": "Normal Dibucaine number is?",
      "options": [
        {
          "label": "A",
          "text": "20",
          "correct": false
        },
        {
          "label": "B",
          "text": "40",
          "correct": false
        },
        {
          "label": "C",
          "text": "80",
          "correct": true
        },
        {
          "label": "D",
          "text": "100",
          "correct": false
        }
      ],
      "correct_answer": "C. 80",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. 80</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 The Dibucaine number is a laboratory test used to assess the function of the enzyme pseudocholinesterase (also known as butyrylcholinesterase ) in the blood .</li><li>\u2022 Dibucaine number</li><li>\u2022 laboratory test</li><li>\u2022 assess the function</li><li>\u2022 enzyme pseudocholinesterase</li><li>\u2022 butyrylcholinesterase</li><li>\u2022 blood</li><li>\u2022 Pseudocholinesterase is an enzyme responsible for breaking down certain drugs , including the muscle relaxant succinylcholine (also known as suxamethonium ).</li><li>\u2022 enzyme responsible for breaking down certain drugs</li><li>\u2022 muscle relaxant succinylcholine</li><li>\u2022 suxamethonium</li><li>\u2022 Normal Dibucaine Number : In individuals with normal pseudocholinesterase activity , the Dibucaine number is typically around 80 . This means that Dibucaine, a specific local anesthetic , can inhibit 80% of the enzyme's activity . In other words, Dibucaine has a moderate effect on slowing down the breakdown of certain drugs by pseudocholinesterase in individuals with a Dibucaine number of 80 . Abnormal Dibucaine Number : Some individuals may have genetic variations that lead to abnormal pseudocholinesterase function . For example, individuals who are homozygous for an atypical form of pseudocholinesterase may have a Dibucaine number as low as 20 . In such cases, Dibucaine has a much stronger inhibitory effect on the enzyme's activity . Clinical Significance : The Dibucaine number is clinically relevant when using drugs like succinylcholine, a muscle relaxant often used during anesthesia . Pseudocholinesterase plays a crucial role in rapidly breaking down succinylcholine , allowing the muscles to regain their function after its use. If a patient has an abnormal Dibucaine number (e.g., 20), it indicates reduced pseudocholinesterase activity . As a result, the patient may experience delayed recovery from muscle relaxation induced by succinylcholine .</li><li>\u2022 Normal Dibucaine Number : In individuals with normal pseudocholinesterase activity , the Dibucaine number is typically around 80 . This means that Dibucaine, a specific local anesthetic , can inhibit 80% of the enzyme's activity . In other words, Dibucaine has a moderate effect on slowing down the breakdown of certain drugs by pseudocholinesterase in individuals with a Dibucaine number of 80 .</li><li>\u2022 Normal Dibucaine Number</li><li>\u2022 normal pseudocholinesterase activity</li><li>\u2022 typically around 80</li><li>\u2022 specific local anesthetic</li><li>\u2022 inhibit 80% of the enzyme's activity</li><li>\u2022 moderate effect</li><li>\u2022 slowing down</li><li>\u2022 breakdown</li><li>\u2022 pseudocholinesterase</li><li>\u2022 individuals</li><li>\u2022 Dibucaine number of 80</li><li>\u2022 Abnormal Dibucaine Number : Some individuals may have genetic variations that lead to abnormal pseudocholinesterase function . For example, individuals who are homozygous for an atypical form of pseudocholinesterase may have a Dibucaine number as low as 20 . In such cases, Dibucaine has a much stronger inhibitory effect on the enzyme's activity .</li><li>\u2022 Abnormal Dibucaine Number</li><li>\u2022 genetic variations</li><li>\u2022 lead</li><li>\u2022 abnormal pseudocholinesterase function</li><li>\u2022 individuals</li><li>\u2022 homozygous</li><li>\u2022 atypical form</li><li>\u2022 pseudocholinesterase</li><li>\u2022 Dibucaine number as low as 20</li><li>\u2022 much stronger inhibitory effect</li><li>\u2022 enzyme's activity</li><li>\u2022 Clinical Significance : The Dibucaine number is clinically relevant when using drugs like succinylcholine, a muscle relaxant often used during anesthesia . Pseudocholinesterase plays a crucial role in rapidly breaking down succinylcholine , allowing the muscles to regain their function after its use. If a patient has an abnormal Dibucaine number (e.g., 20), it indicates reduced pseudocholinesterase activity . As a result, the patient may experience delayed recovery from muscle relaxation induced by succinylcholine .</li><li>\u2022 Clinical Significance</li><li>\u2022 clinically relevant</li><li>\u2022 muscle relaxant</li><li>\u2022 during anesthesia</li><li>\u2022 crucial role</li><li>\u2022 rapidly breaking down succinylcholine</li><li>\u2022 allowing the muscles</li><li>\u2022 regain their function</li><li>\u2022 abnormal Dibucaine number</li><li>\u2022 indicates reduced pseudocholinesterase activity</li><li>\u2022 experience delayed recovery</li><li>\u2022 muscle relaxation induced by succinylcholine</li><li>\u2022 Educational objective :</li><li>\u2022 Educational objective</li><li>\u2022 The Dibucaine number is a measure of pseudocholinesterase function , and a normal value is around 80 . Abnormal values, particularly a low Dibucaine number , can have clinical implications , especially when using drugs like succinylcholine during surgery.</li><li>\u2022 measure of pseudocholinesterase function</li><li>\u2022 normal value is around 80</li><li>\u2022 low Dibucaine number</li><li>\u2022 clinical implications</li><li>\u2022 Ref : Millers Anesthesia 8 th edition pg 962</li><li>\u2022 Ref :</li><li>\u2022 Millers Anesthesia 8 th edition pg 962</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "da23a99e",
      "audio": ""
    },
    {
      "text": "Succinylcholine was first synthesized by?",
      "options": [
        {
          "label": "A",
          "text": "Lundy",
          "correct": false
        },
        {
          "label": "B",
          "text": "WTG Morton",
          "correct": false
        },
        {
          "label": "C",
          "text": "Bovet",
          "correct": true
        },
        {
          "label": "D",
          "text": "John snow",
          "correct": false
        }
      ],
      "correct_answer": "C. Bovet",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. Bovet</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A . John S. Lundy : He was one of the first to use the term \" Balanced Anesthesia \" and contributed to the widespread use of local and regional anesthesia techniques .</li><li>\u2022 Option A</li><li>\u2022 John S. Lundy</li><li>\u2022 one of the first to use the term</li><li>\u2022 Balanced Anesthesia</li><li>\u2022 contributed</li><li>\u2022 widespread use of local and regional anesthesia techniques</li><li>\u2022 Option B . WTG Morton : William Thomas Green Morton was a dentist and a prominent figure in the history of anesthesia. He is best known for his successful public demonstration of the use of ether as a surgical anesthetic in 1846 , which revolutionized surgical practice by allowing patients to undergo procedures without pain .</li><li>\u2022 Option B</li><li>\u2022 WTG Morton</li><li>\u2022 William Thomas Green Morton</li><li>\u2022 dentist</li><li>\u2022 prominent figure</li><li>\u2022 best known</li><li>\u2022 successful public demonstration</li><li>\u2022 use of ether</li><li>\u2022 surgical anesthetic</li><li>\u2022 1846</li><li>\u2022 revolutionized surgical practice</li><li>\u2022 allowing patients</li><li>\u2022 undergo procedures</li><li>\u2022 without pain</li><li>\u2022 Option D . John Snow : John Snow is often called the father of modern epidemiology . He's most famous for his work in tracing the source of a cholera outbreak in London in 1854 , which he linked to a contaminated water pump . His work laid the foundations for modern epidemiology and public health . Snow also made significant contributions to anesthesiology and is known for his work on ether and chloroform .</li><li>\u2022 Option D</li><li>\u2022 John Snow</li><li>\u2022 called the father of modern epidemiology</li><li>\u2022 most famous</li><li>\u2022 work in tracing</li><li>\u2022 source of a cholera outbreak in London in 1854</li><li>\u2022 linked to a contaminated water pump</li><li>\u2022 laid the foundations</li><li>\u2022 modern epidemiology and public health</li><li>\u2022 significant contributions</li><li>\u2022 anesthesiology</li><li>\u2022 work on ether and chloroform</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 Succinylcholine was first synthesized by Bovet</li><li>\u27a4 Succinylcholine was first synthesized by Bovet</li><li>\u27a4 Ref : Millers Anesthesia 8 th edition pg 1020</li><li>\u27a4 Ref :</li><li>\u27a4 Millers Anesthesia 8 th edition pg 1020</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "a5f1420b",
      "audio": ""
    },
    {
      "text": "Which of the following is not a side effect of succinylcholine?",
      "options": [
        {
          "label": "A",
          "text": "Sinus Tachycardia",
          "correct": true
        },
        {
          "label": "B",
          "text": "Hyperkalaemia",
          "correct": false
        },
        {
          "label": "C",
          "text": "Myalgia",
          "correct": false
        },
        {
          "label": "D",
          "text": "Masseter Spasm",
          "correct": false
        }
      ],
      "correct_answer": "A. Sinus Tachycardia",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/26/untitled-102.jpg"
      ],
      "explanation": "<p><strong>Ans. A. Sinus Tachycardia</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B . Hyperkalemia : Succinylcholine can cause an increase in serum potassium levels , which is especially risky in patients with pre-existing hyperkalemia or those with risk factors for increased potassium release , such as burn or crush injuries, neuromuscular diseases , or prolonged immobilization .</li><li>\u2022 Option B</li><li>\u2022 Hyperkalemia</li><li>\u2022 increase</li><li>\u2022 serum potassium levels</li><li>\u2022 especially risky</li><li>\u2022 pre-existing hyperkalemia</li><li>\u2022 risk factors</li><li>\u2022 increased potassium release</li><li>\u2022 neuromuscular diseases</li><li>\u2022 prolonged immobilization</li><li>\u2022 Option C . Myalgia : Muscle pain , or myalgia, is a common side effect following the administration of succinylcholine due to muscle fasciculations that occur before muscle relaxation . It is often experienced as generalized muscle soreness after recovery from anesthesia .</li><li>\u2022 Option C</li><li>\u2022 Myalgia</li><li>\u2022 Muscle pain</li><li>\u2022 common side effect</li><li>\u2022 succinylcholine</li><li>\u2022 muscle fasciculations</li><li>\u2022 before muscle relaxation</li><li>\u2022 often experienced</li><li>\u2022 generalized muscle soreness</li><li>\u2022 recovery from anesthesia</li><li>\u2022 Option D . Masseter Spasm : This is a known side effect of succinylcholine and is considered an early sign of malignant hyperthermia , a rare but life-threatening reaction to certain drugs used for anesthesia .</li><li>\u2022 Option D</li><li>\u2022 Masseter Spasm</li><li>\u2022 known side effect</li><li>\u2022 succinylcholine</li><li>\u2022 early sign of malignant hyperthermia</li><li>\u2022 rare</li><li>\u2022 life-threatening reaction</li><li>\u2022 drugs used for anesthesia</li><li>\u2022 Educational objective:</li><li>\u2022 Educational objective:</li><li>\u2022 Cardiovascular side effects of succinylcholine:</li><li>\u2022 Cardiovascular side effects of succinylcholine:</li><li>\u2022 Sinus Bradycardia Junctional Rhythm Ventricular Dysrhythmias</li><li>\u2022 Sinus Bradycardia</li><li>\u2022 Junctional Rhythm</li><li>\u2022 Ventricular Dysrhythmias</li><li>\u2022 Ref : Millers Anesthesia 8 th edition pg 962-964</li><li>\u2022 Ref :</li><li>\u2022 Millers Anesthesia 8 th edition pg 962-964</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "d7cd97ff",
      "audio": ""
    },
    {
      "text": "Use of succinylcholine increases plasma K+ level by ------ mEq/L?",
      "options": [
        {
          "label": "A",
          "text": "0.25 mEq/L",
          "correct": false
        },
        {
          "label": "B",
          "text": "0.5 mEq/L",
          "correct": true
        },
        {
          "label": "C",
          "text": "1 mEq/L",
          "correct": false
        },
        {
          "label": "D",
          "text": "1.5 mEq/L",
          "correct": false
        }
      ],
      "correct_answer": "B. 0.5 mEq/L",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. 0.5 mEq/L</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Succinylcholine is known to cause an elevation in plasma potassium levels due the following mechanism of action .</li><li>\u2022 Succinylcholine</li><li>\u2022 elevation in plasma potassium levels</li><li>\u2022 mechanism of action</li><li>\u2022 When succinylcholine is administered , it binds to nicotinic acetylcholine receptors at the neuromuscular junction , leading to depolarization of the muscle cell membrane . This depolarization causes the muscle cells to release potassium into the bloodstream .</li><li>\u2022 administered</li><li>\u2022 binds to nicotinic acetylcholine receptors</li><li>\u2022 neuromuscular junction</li><li>\u2022 depolarization of the muscle cell membrane</li><li>\u2022 depolarization</li><li>\u2022 muscle cells</li><li>\u2022 release potassium</li><li>\u2022 bloodstream</li><li>\u2022 The use of succinylcholine typically increases plasma potassium levels by about 0.5 mEq/L . This increase is usually clinically insignificant in healthy patients but can be dangerous in patients with higher baseline levels of potassium or in those with conditions that predispose them to hyperkalemia , such as renal failure, burn injuries , or neuromuscular disorders . It's important to monitor potassium levels after administration , especially in patients at risk for hyperkalemia.</li><li>\u2022 increases plasma potassium levels</li><li>\u2022 about 0.5 mEq/L</li><li>\u2022 increase</li><li>\u2022 usually clinically insignificant</li><li>\u2022 healthy patients</li><li>\u2022 dangerous</li><li>\u2022 patients</li><li>\u2022 higher baseline levels</li><li>\u2022 potassium</li><li>\u2022 predispose them to hyperkalemia</li><li>\u2022 renal failure, burn injuries</li><li>\u2022 neuromuscular disorders</li><li>\u2022 important</li><li>\u2022 monitor potassium levels after administration</li><li>\u2022 patients at risk for hyperkalemia.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 Use of succinylcholine increases plasma K+ level by 0.5 mEq/L .</li><li>\u27a4 Use of succinylcholine increases plasma K+ level by 0.5 mEq/L .</li><li>\u27a4 Ref : Millers Anesthesia 8 th edition pg 962-964</li><li>\u27a4 Ref :</li><li>\u27a4 Millers Anesthesia 8 th edition pg 962-964</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "b252f628",
      "audio": ""
    },
    {
      "text": "While giving non-depolarizing neuromuscular blockade which nerve is commonly used for monitoring the intensity of the blockade?",
      "options": [
        {
          "label": "A",
          "text": "Posterior Tibial Nerve",
          "correct": false
        },
        {
          "label": "B",
          "text": "Ulnar Nerve",
          "correct": true
        },
        {
          "label": "C",
          "text": "Radial Nerve",
          "correct": false
        },
        {
          "label": "D",
          "text": "Facial Nerve",
          "correct": false
        }
      ],
      "correct_answer": "B. Ulnar Nerve",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/26/untitled-103.jpg"
      ],
      "explanation": "<p><strong>Ans. B. Ulnar Nerve</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A . Posterior Tibial Nerve : While this nerve can be used for monitoring , it is less commonly chosen because of its location and the bulkier muscles it innervates , which might not be as accessible during many surgical procedures.</li><li>\u2022 Option A</li><li>\u2022 Posterior Tibial Nerve</li><li>\u2022 monitoring</li><li>\u2022 less commonly chosen</li><li>\u2022 location</li><li>\u2022 bulkier muscles</li><li>\u2022 innervates</li><li>\u2022 not</li><li>\u2022 accessible</li><li>\u2022 Option C . Radial Nerve : Less commonly used for standard monitoring, as its primary innervated muscles in the arm and back of the hand are not as responsive for assessing subtle degrees of neuromuscular blockade compared to the muscles innervated by the ulnar nerve.</li><li>\u2022 Option C</li><li>\u2022 Radial Nerve</li><li>\u2022 Less commonly used</li><li>\u2022 primary innervated muscles</li><li>\u2022 arm and back</li><li>\u2022 hand</li><li>\u2022 Option D . Facial Nerve : Although the facial nerve can be used , especially during head and neck surgeries , it's less common for general procedures . The facial expressions caused by its stimulation can be more subjective and less quantifiable compared to the hand's muscle responses to ulnar nerve stimulation.</li><li>\u2022 Option D</li><li>\u2022 Facial Nerve</li><li>\u2022 facial nerve can be used</li><li>\u2022 during head and neck surgeries</li><li>\u2022 less common for general procedures</li><li>\u2022 facial expressions</li><li>\u2022 stimulation</li><li>\u2022 more subjective</li><li>\u2022 less quantifiable</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 Ulnar nerve is the most commonly used nerve for monitoring neuromuscular blockade</li><li>\u27a4 Ulnar nerve is the most commonly used nerve for monitoring neuromuscular blockade</li><li>\u27a4 Ref : Millers Anesthesia 8 th edition pg 1610</li><li>\u27a4 Ref :</li><li>\u27a4 Millers Anesthesia 8 th edition pg 1610</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "fe94ece0",
      "audio": ""
    },
    {
      "text": "Administration of a small dose of a non-depolarizing neuromuscular blocking agent a few minutes before succinylcholine to minimize the complications of succinylcholine is called as?",
      "options": [
        {
          "label": "A",
          "text": "Recurarization",
          "correct": false
        },
        {
          "label": "B",
          "text": "Precurarization",
          "correct": true
        },
        {
          "label": "C",
          "text": "Atracurarization",
          "correct": false
        },
        {
          "label": "D",
          "text": "Reverse Curarization",
          "correct": false
        }
      ],
      "correct_answer": "B. Precurarization",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. Precurarization</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "a8e960b9",
      "audio": ""
    },
    {
      "text": "Desensitization of Acetylcholine receptors after giving a large dose or continuous bolus doses of succinylcholine, resulting in prolonged neuromuscular blockade is called as?",
      "options": [
        {
          "label": "A",
          "text": "Phase I block",
          "correct": false
        },
        {
          "label": "B",
          "text": "Phase II block",
          "correct": true
        },
        {
          "label": "C",
          "text": "Phase III block",
          "correct": false
        },
        {
          "label": "D",
          "text": "Phase IV block",
          "correct": false
        }
      ],
      "correct_answer": "B. Phase II block",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. Phase II Block</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Succinylcholine, also known as suxamethonium , is a depolarizing muscle relaxant that can produce two types of neuromuscular blocks, Phase I and Phase II , which has distinct characteristics:</li><li>\u2022 suxamethonium</li><li>\u2022 depolarizing muscle relaxant</li><li>\u2022 two types</li><li>\u2022 Phase I and Phase II</li><li>\u2022 Phase I Block:</li><li>\u2022 Phase I Block:</li><li>\u2022 Rapid Onset : Succinylcholine acts quickly , causing depolarization of the muscle endplate shortly after administration . Persistent Depolarization : It continuously stimulates the nicotinic receptors at the neuromuscular junction , causing persistent depolarization and resulting in muscle paralysis . Depolarization Block Features : This includes sustained muscle fasciculations followed by flaccid paralysis . Anticholinesterase Resistance : The block cannot be reversed by anticholinesterase drugs like neostigmine because these drugs increase the amount of acetylcholine , which is ineffective once the receptor is depolarized and desensitized .</li><li>\u2022 Rapid Onset : Succinylcholine acts quickly , causing depolarization of the muscle endplate shortly after administration .</li><li>\u2022 Rapid Onset</li><li>\u2022 quickly</li><li>\u2022 depolarization</li><li>\u2022 muscle endplate</li><li>\u2022 shortly after administration</li><li>\u2022 Persistent Depolarization : It continuously stimulates the nicotinic receptors at the neuromuscular junction , causing persistent depolarization and resulting in muscle paralysis .</li><li>\u2022 Persistent Depolarization</li><li>\u2022 continuously</li><li>\u2022 nicotinic receptors</li><li>\u2022 neuromuscular junction</li><li>\u2022 persistent depolarization</li><li>\u2022 resulting</li><li>\u2022 muscle paralysis</li><li>\u2022 Depolarization Block Features : This includes sustained muscle fasciculations followed by flaccid paralysis .</li><li>\u2022 Depolarization Block Features</li><li>\u2022 sustained muscle fasciculations</li><li>\u2022 flaccid paralysis</li><li>\u2022 Anticholinesterase Resistance : The block cannot be reversed by anticholinesterase drugs like neostigmine because these drugs increase the amount of acetylcholine , which is ineffective once the receptor is depolarized and desensitized .</li><li>\u2022 Anticholinesterase Resistance</li><li>\u2022 cannot</li><li>\u2022 reversed by anticholinesterase drugs</li><li>\u2022 increase the amount of acetylcholine</li><li>\u2022 ineffective</li><li>\u2022 receptor is depolarized and desensitized</li><li>\u2022 Phase II Block (Dual Block):</li><li>\u2022 Phase II Block (Dual Block):</li><li>\u2022 Slow Onset : With prolonged exposure to succinylcholine or after repeated doses , the receptor becomes desensitized , leading to a slower onset of blockade . Desensitization of Receptors : The acetylcholine receptors become unresponsive to acetylcholine , which is similar to the mechanism seen with non-depolarizing (competitive) blockers . Similarity to Non-Depolarizing Block : The characteristics of Phase II block are akin to those produced by competitive blockers , and the block can be partially reversed by anticholinesterase drugs . Conditions for Occurrence : Phase II block is more likely to be seen when large doses of succinylcholine are used, with the administration of certain anesthetics like fluorinated anesthetics , or in patients with atypical or deficient pseudocholinesterase , which slows the breakdown of succinylcholine .</li><li>\u2022 Slow Onset : With prolonged exposure to succinylcholine or after repeated doses , the receptor becomes desensitized , leading to a slower onset of blockade .</li><li>\u2022 Slow Onset</li><li>\u2022 prolonged exposure</li><li>\u2022 succinylcholine</li><li>\u2022 after repeated doses</li><li>\u2022 becomes desensitized</li><li>\u2022 slower onset of blockade</li><li>\u2022 Desensitization of Receptors : The acetylcholine receptors become unresponsive to acetylcholine , which is similar to the mechanism seen with non-depolarizing (competitive) blockers .</li><li>\u2022 Desensitization of Receptors</li><li>\u2022 acetylcholine receptors</li><li>\u2022 unresponsive</li><li>\u2022 acetylcholine</li><li>\u2022 mechanism</li><li>\u2022 non-depolarizing (competitive) blockers</li><li>\u2022 Similarity to Non-Depolarizing Block : The characteristics of Phase II block are akin to those produced by competitive blockers , and the block can be partially reversed by anticholinesterase drugs .</li><li>\u2022 Similarity to Non-Depolarizing Block</li><li>\u2022 produced by competitive blockers</li><li>\u2022 block</li><li>\u2022 partially reversed</li><li>\u2022 anticholinesterase drugs</li><li>\u2022 Conditions for Occurrence : Phase II block is more likely to be seen when large doses of succinylcholine are used, with the administration of certain anesthetics like fluorinated anesthetics , or in patients with atypical or deficient pseudocholinesterase , which slows the breakdown of succinylcholine .</li><li>\u2022 Conditions for Occurrence</li><li>\u2022 seen</li><li>\u2022 large doses</li><li>\u2022 administration</li><li>\u2022 fluorinated anesthetics</li><li>\u2022 atypical</li><li>\u2022 deficient pseudocholinesterase</li><li>\u2022 slows the breakdown of succinylcholine</li><li>\u2022 Ref : Morgan and Mikhail\u2019s clinical Anesthesiology 5 th edition pg 210</li><li>\u2022 Ref :</li><li>\u2022 Morgan and Mikhail\u2019s clinical Anesthesiology 5 th edition pg 210</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "4bce7ea4",
      "audio": ""
    },
    {
      "text": "What is the site of action of Rocuronium?",
      "options": [
        {
          "label": "A",
          "text": "Cerebellum",
          "correct": false
        },
        {
          "label": "B",
          "text": "Reticular Formation",
          "correct": false
        },
        {
          "label": "C",
          "text": "Motor Neuron",
          "correct": false
        },
        {
          "label": "D",
          "text": "Neuro-Muscular Junction",
          "correct": true
        }
      ],
      "correct_answer": "D. Neuro-Muscular Junction",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D. Neuro-Muscular Junction</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A . Cerebellum: The cerebellum is involved in coordination of movement . Rocuronium does not act here.</li><li>\u2022 Option A</li><li>\u2022 Cerebellum:</li><li>\u2022 coordination of movement</li><li>\u2022 does not act</li><li>\u2022 Option B . Reticular Formation : This is a network in the brainstem involved in consciousness and arousal . Rocuronium does not act here.</li><li>\u2022 Option B</li><li>\u2022 Reticular Formation</li><li>\u2022 network</li><li>\u2022 brainstem</li><li>\u2022 consciousness and arousal</li><li>\u2022 does not act</li><li>\u2022 Option C . Motor Neuron : While motor neurons are involved in transmitting signals from the nervous system to muscles , rocuronium specifically acts at the synapse where motor neurons meet muscle cells , not on the motor neuron itself.</li><li>\u2022 Option C</li><li>\u2022 Motor Neuron</li><li>\u2022 transmitting signals</li><li>\u2022 nervous system to muscles</li><li>\u2022 synapse</li><li>\u2022 motor neurons</li><li>\u2022 meet muscle cells</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 Rocuronium is a non-depolarizing neuromuscular blocker that acts on the nicotinic receptors at the neuromuscular junction , preventing muscle contraction by competing with acetylcholine for receptor sites .</li><li>\u27a4 non-depolarizing neuromuscular blocker</li><li>\u27a4 nicotinic receptors</li><li>\u27a4 neuromuscular junction</li><li>\u27a4 muscle contraction</li><li>\u27a4 acetylcholine for receptor sites</li><li>\u27a4 Ref : Morgan and Mikhail\u2019s clinical anesthesiology 7 th edition pg 372-373</li><li>\u27a4 Ref :</li><li>\u27a4 Morgan and Mikhail\u2019s clinical anesthesiology 7 th edition pg 372-373</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "25e24cd6",
      "audio": ""
    },
    {
      "text": "Malignant hyperthermia is caused by all of the following except?",
      "options": [
        {
          "label": "A",
          "text": "Succinylcholine",
          "correct": false
        },
        {
          "label": "B",
          "text": "Dantrolene",
          "correct": true
        },
        {
          "label": "C",
          "text": "Halothane",
          "correct": false
        },
        {
          "label": "D",
          "text": "Methoxyflurane",
          "correct": false
        }
      ],
      "correct_answer": "B. Dantrolene",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. Dantrolene</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Malignant hyperthermia (MH) is a rare but life-threatening condition often triggered by certain general anesthetic agents .</li><li>\u2022 rare but life-threatening condition</li><li>\u2022 triggered</li><li>\u2022 certain general anesthetic agents</li><li>\u2022 Option A . Succinylcholine : This depolarizing muscle relaxant is a known trigger for malignant hyperthermia in susceptible individuals due to its action on the ryanodine receptor in the sarcoplasmic reticulum of muscle cells.</li><li>\u2022 Option A</li><li>\u2022 Succinylcholine</li><li>\u2022 depolarizing muscle relaxant</li><li>\u2022 known trigger</li><li>\u2022 susceptible individuals</li><li>\u2022 action on the ryanodine receptor</li><li>\u2022 sarcoplasmic reticulum</li><li>\u2022 Option C . Halothane : An inhalational anesthetic that is a well-documented trigger for malignant hyperthermia due to its effect on calcium channels in muscle cells .</li><li>\u2022 Option C</li><li>\u2022 Halothane</li><li>\u2022 inhalational anesthetic</li><li>\u2022 trigger</li><li>\u2022 effect on calcium channels</li><li>\u2022 muscle cells</li><li>\u2022 Option D. Methoxyflurane : Another inhalational anesthetic that can trigger malignant hyperthermia in susceptible individuals .</li><li>\u2022 Option D.</li><li>\u2022 Methoxyflurane</li><li>\u2022 inhalational anesthetic</li><li>\u2022 trigger</li><li>\u2022 susceptible individuals</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 Dantrolene is used to treat malignant hyperthermia and is not a trigger for the condition, unlike succinylcholine, halothane, and methoxyflurane, which can all precipitate this pharmacogenetic crisis.</li><li>\u27a4 treat malignant hyperthermia</li><li>\u27a4 not a trigger</li><li>\u27a4 MALIGNANT HYPERTHERMIA</li><li>\u27a4 MALIGNANT HYPERTHERMIA</li><li>\u27a4 It is a medical emergency characterized by raised body temperature , altered mental status and rigidity .</li><li>\u27a4 medical emergency</li><li>\u27a4 raised body temperature</li><li>\u27a4 altered mental status</li><li>\u27a4 rigidity</li><li>\u27a4 Mutation - RyR/DHPR Gene Mutation Ion responsible - Calcium Most sensitive/earliest symptom - Masseter Spasm Earliest finding - Sudden increase in EtCO 2 (>45 mmHg) Late - Fever Drugs causing Malignant Hyperthermia- Lignocaine Succinylcholine Inhalational Anesthetic Agents - Halothane, Isoflurane, Desflurane, Sevoflurane, Methoxyflurane TCA, MAO inhibitors Drug of choice - Dantrolene Sodium</li><li>\u27a4 Mutation - RyR/DHPR Gene Mutation</li><li>\u27a4 Mutation</li><li>\u27a4 RyR/DHPR Gene Mutation</li><li>\u27a4 Ion responsible - Calcium</li><li>\u27a4 Ion responsible</li><li>\u27a4 Calcium</li><li>\u27a4 Most sensitive/earliest symptom - Masseter Spasm</li><li>\u27a4 Most sensitive/earliest symptom</li><li>\u27a4 Masseter Spasm</li><li>\u27a4 Earliest finding - Sudden increase in EtCO 2 (>45 mmHg)</li><li>\u27a4 Earliest finding</li><li>\u27a4 Sudden increase in EtCO 2 (>45 mmHg)</li><li>\u27a4 Late - Fever</li><li>\u27a4 Late - Fever</li><li>\u27a4 Drugs causing Malignant Hyperthermia- Lignocaine Succinylcholine Inhalational Anesthetic Agents - Halothane, Isoflurane, Desflurane, Sevoflurane,</li><li>\u27a4 Drugs causing Malignant Hyperthermia-</li><li>\u27a4 Lignocaine Succinylcholine Inhalational Anesthetic Agents - Halothane, Isoflurane, Desflurane, Sevoflurane,</li><li>\u27a4 Lignocaine</li><li>\u27a4 Succinylcholine</li><li>\u27a4 Inhalational Anesthetic Agents - Halothane, Isoflurane, Desflurane, Sevoflurane,</li><li>\u27a4 Methoxyflurane TCA, MAO inhibitors</li><li>\u27a4 Methoxyflurane</li><li>\u27a4 TCA, MAO inhibitors</li><li>\u27a4 TCA, MAO inhibitors</li><li>\u27a4 Drug of choice - Dantrolene Sodium</li><li>\u27a4 Drug of choice</li><li>\u27a4 Dantrolene Sodium</li><li>\u27a4 Ref : Morgan and Mikhail\u2019s clinical anesthesiology 7 th edition pg 2297</li><li>\u27a4 Ref :</li><li>\u27a4 Morgan and Mikhail\u2019s clinical anesthesiology 7 th edition pg 2297</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "92f05633",
      "audio": ""
    },
    {
      "text": "Which of the following statements about depolarizing neuromuscular blockade produced by succinylcholine is false?",
      "options": [
        {
          "label": "A",
          "text": "Post Tetanic Facilitation and Fade Absent",
          "correct": false
        },
        {
          "label": "B",
          "text": "Train of Four Ratio > 0.4 but no Fade",
          "correct": false
        },
        {
          "label": "C",
          "text": "Block is Reversed by Neostigmine",
          "correct": true
        },
        {
          "label": "D",
          "text": "Fasciculation & Block potentiated by Volatile Anaesthetic Agents",
          "correct": false
        }
      ],
      "correct_answer": "C. Block is Reversed by Neostigmine",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/19/screenshot-2023-12-19-125747.jpg"
      ],
      "explanation": "<p><strong>Ans. C. Block is Reversed by Neostigmine</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Depolarizing neuromuscular blockade produced by succinylcholine has unique characteristics :</li><li>\u2022 Depolarizing neuromuscular blockade</li><li>\u2022 succinylcholine</li><li>\u2022 unique characteristics</li><li>\u2022 Option A . Post-Tetanic Facilitation and Fade Absent : In depolarizing blockade, post-tetanic potentiation or facilitation and fade are typically absent because the mechanism of blockade is persistent depolarization , not receptor competition or presynaptic inhibition of acetylcholine release.</li><li>\u2022 Option A</li><li>\u2022 Post-Tetanic Facilitation and Fade Absent</li><li>\u2022 typically absent</li><li>\u2022 mechanism of blockade</li><li>\u2022 persistent depolarization</li><li>\u2022 Option B . Train of Four Ratio > 0.4 but No Fade : With succinylcholine-induced depolarizing blockade, the train of four (TOF) ratio can be greater than 0.4 without fade because the block is characterized by a persistent depolarization of the neuromuscular endplate , not an interference with acetylcholine binding as seen with non-depolarizing blockers.</li><li>\u2022 Option B</li><li>\u2022 Train of Four Ratio > 0.4 but No Fade</li><li>\u2022 block</li><li>\u2022 persistent depolarization</li><li>\u2022 neuromuscular endplate</li><li>\u2022 Option D . Fasciculation & Block Potentiated by Volatile Anesthetic Agents : Volatile anesthetics are known to potentiate the effects of succinylcholine , leading to more pronounced fasciculations and a deeper neuromuscular block .</li><li>\u2022 Option D</li><li>\u2022 Fasciculation & Block Potentiated by Volatile Anesthetic Agents</li><li>\u2022 potentiate</li><li>\u2022 effects of succinylcholine</li><li>\u2022 pronounced fasciculations</li><li>\u2022 deeper neuromuscular block</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "3320ee86",
      "audio": ""
    },
    {
      "text": "A 40-year-old female was given fentanyl, propofol and pancuronium for induction of anesthesia. After extubation she was observed to have limited movement of the upper body and chest wall in the recovery room. She was conscious and alert, but voluntary respiratory effort was limited. What is the likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Incomplete Reversal of Pancuronium",
          "correct": true
        },
        {
          "label": "B",
          "text": "Pulmonary Embolism",
          "correct": false
        },
        {
          "label": "C",
          "text": "Fentanyl Induced Chest Wall Rigidity",
          "correct": false
        },
        {
          "label": "D",
          "text": "Diffusion Hypoxia",
          "correct": false
        }
      ],
      "correct_answer": "A. Incomplete Reversal of Pancuronium",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A. Incomplete Reversal of Pancuronium</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 The clinical scenario describes a situation where the patient is conscious and alert but has limited voluntary movement , particularly in the upper body and respiratory effort , after anesthesia.</li><li>\u2022 conscious</li><li>\u2022 alert</li><li>\u2022 limited voluntary movement</li><li>\u2022 upper body</li><li>\u2022 respiratory effort</li><li>\u2022 Let\u2019s evaluate each option:</li><li>\u2022 Let\u2019s evaluate each option:</li><li>\u2022 Option B . Pulmonary Embolism : While it can lead to respiratory distress , the patient would likely exhibit signs of acute distress , hypoxia , and hemodynamic instability , not alertness with isolated respiratory effort limitation .</li><li>\u2022 Option B</li><li>\u2022 Pulmonary Embolism</li><li>\u2022 lead to respiratory distress</li><li>\u2022 exhibit signs</li><li>\u2022 acute distress</li><li>\u2022 hypoxia</li><li>\u2022 hemodynamic instability</li><li>\u2022 not alertness with isolated respiratory effort limitation</li><li>\u2022 Option C . Fentanyl Induced Chest Wall Rigidity : High doses of fentanyl can cause chest wall rigidity , making ventilation difficult . However, this typically occurs during or immediately after rapid intravenous administration , not during the recovery period.</li><li>\u2022 Option C</li><li>\u2022 Fentanyl Induced Chest Wall Rigidity</li><li>\u2022 High doses</li><li>\u2022 fentanyl</li><li>\u2022 cause chest wall rigidity</li><li>\u2022 making ventilation difficult</li><li>\u2022 typically</li><li>\u2022 during or immediately</li><li>\u2022 rapid intravenous administration</li><li>\u2022 Option D . Diffusion Hypoxia : This occurs after the discontinuation of nitrous oxide anesthesia when there is a rapid diffusion of nitrous oxide out of the blood into the lungs , diluting the oxygen and leading to transient hypoxia . It would not typically cause limited movement as described.</li><li>\u2022 Option D</li><li>\u2022 Diffusion Hypoxia</li><li>\u2022 discontinuation of nitrous oxide anesthesia</li><li>\u2022 rapid diffusion</li><li>\u2022 nitrous oxide</li><li>\u2022 out</li><li>\u2022 blood into the lungs</li><li>\u2022 diluting the oxygen</li><li>\u2022 leading to transient hypoxia</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 The most likely diagnosis when a patient is alert with limited upper body and chest wall movement after anesthesia is incomplete reversal of pancuronium , a long-acting non-depolarizing neuromuscular blocker , which can result in residual paralysis affecting voluntary muscle movements , including respiration.</li><li>\u27a4 alert with limited upper body</li><li>\u27a4 chest wall movement</li><li>\u27a4 incomplete reversal of pancuronium</li><li>\u27a4 long-acting non-depolarizing neuromuscular blocker</li><li>\u27a4 result in residual paralysis</li><li>\u27a4 affecting voluntary muscle movements</li><li>\u27a4 Ref : Millers Anesthesia 8 th edition pg 1610</li><li>\u27a4 Ref :</li><li>\u27a4 Millers Anesthesia 8 th edition pg 1610</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "e02b213d",
      "audio": ""
    },
    {
      "text": "Which of the following drugs undergoes Hoffman elimination?",
      "options": [
        {
          "label": "A",
          "text": "Atracurium",
          "correct": true
        },
        {
          "label": "B",
          "text": "Mivacurium",
          "correct": false
        },
        {
          "label": "C",
          "text": "Pancuronium",
          "correct": false
        },
        {
          "label": "D",
          "text": "Tubocurarine",
          "correct": false
        }
      ],
      "correct_answer": "A. Atracurium",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A. Atracurium</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Atracurium Pharmacokinetics:</li><li>\u2022 Atracurium Pharmacokinetics:</li><li>\u2022 Dose: 0.5 mg/kg Onset of action : 2\u20133 minutes ; Duration of action : 10\u201315 minutes</li><li>\u2022 Dose: 0.5 mg/kg</li><li>\u2022 Dose: 0.5 mg/kg</li><li>\u2022 Onset of action : 2\u20133 minutes ;</li><li>\u2022 Onset of action</li><li>\u2022 2\u20133 minutes</li><li>\u2022 Duration of action : 10\u201315 minutes</li><li>\u2022 Duration of action</li><li>\u2022 10\u201315 minutes</li><li>\u2022 Metabolism</li><li>\u2022 Metabolism</li><li>\u2022 It undergoes spontaneous degradation in plasma through Hoffman degradation , which is independent of hepatic & renal functions .</li><li>\u2022 It undergoes spontaneous degradation in plasma through Hoffman degradation , which is independent of hepatic & renal functions .</li><li>\u2022 undergoes</li><li>\u2022 spontaneous degradation</li><li>\u2022 through Hoffman degradation</li><li>\u2022 independent</li><li>\u2022 hepatic & renal functions</li><li>\u2022 Systemic Effects</li><li>\u2022 Systemic Effects</li><li>\u2022 Histamine release causes flushing , hypotension , and bronchospasm . CNS : At higher doses , it is metabolized to laudanosine , which can cross blood brain barrier & produce convulsions . Allergic reactions can occur. It is the muscle relaxant of choice in the following groups of patients because its metabolism is independent of renal and liver functions . Hepatic failure Renal failure If reversal agent is contraindicated, e.g., Myasthenia gravis New-borns Old age</li><li>\u2022 Histamine release causes flushing , hypotension , and bronchospasm .</li><li>\u2022 Histamine</li><li>\u2022 flushing</li><li>\u2022 hypotension</li><li>\u2022 bronchospasm</li><li>\u2022 CNS : At higher doses , it is metabolized to laudanosine , which can cross blood brain barrier & produce convulsions .</li><li>\u2022 CNS</li><li>\u2022 higher doses</li><li>\u2022 metabolized</li><li>\u2022 laudanosine</li><li>\u2022 cross blood brain barrier</li><li>\u2022 produce convulsions</li><li>\u2022 Allergic reactions can occur.</li><li>\u2022 Allergic reactions</li><li>\u2022 It is the muscle relaxant of choice in the following groups of patients because its metabolism is independent of renal and liver functions . Hepatic failure Renal failure If reversal agent is contraindicated, e.g., Myasthenia gravis New-borns Old age</li><li>\u2022 muscle relaxant of choice</li><li>\u2022 metabolism is independent of renal and liver functions</li><li>\u2022 Hepatic failure Renal failure If reversal agent is contraindicated, e.g., Myasthenia gravis New-borns Old age</li><li>\u2022 Hepatic failure</li><li>\u2022 Renal failure</li><li>\u2022 If reversal agent is contraindicated, e.g., Myasthenia gravis</li><li>\u2022 New-borns</li><li>\u2022 Old age</li><li>\u2022 Educational objective:</li><li>\u2022 Educational objective:</li><li>\u2022 Atracurium is metabolized by Hoffman elimination , an organ-independent process , making it suitable for use in patients with hepatic or renal failure , as well as in myasthenia gravis , neonates , and the elderly . It has an onset of 2-3 minutes , a short duration of action , but can cause histamine release and, at high doses , produce CNS effects due to laudanosine .</li><li>\u2022 metabolized by Hoffman elimination</li><li>\u2022 organ-independent process</li><li>\u2022 making</li><li>\u2022 suitable for use</li><li>\u2022 hepatic or renal failure</li><li>\u2022 myasthenia gravis</li><li>\u2022 neonates</li><li>\u2022 elderly</li><li>\u2022 onset of 2-3 minutes</li><li>\u2022 short duration of action</li><li>\u2022 histamine release</li><li>\u2022 high doses</li><li>\u2022 CNS effects due to laudanosine</li><li>\u2022 Ref : Morgan and Mikhail\u2019s clinical anesthesiology 7 th edition pg 394</li><li>\u2022 Ref :</li><li>\u2022 Morgan and Mikhail\u2019s clinical anesthesiology 7 th edition pg 394</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "3bca3cc5",
      "audio": ""
    },
    {
      "text": "Most common drug causing allergy in immediate perioperative period is?",
      "options": [
        {
          "label": "A",
          "text": "Opioids",
          "correct": false
        },
        {
          "label": "B",
          "text": "Local anesthetics",
          "correct": false
        },
        {
          "label": "C",
          "text": "Antibiotics",
          "correct": true
        },
        {
          "label": "D",
          "text": "Neuromuscular blockers",
          "correct": false
        }
      ],
      "correct_answer": "C. Antibiotics",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. Antibiotics > Muscle relaxants</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Antibiotics are now the most common cause of anaphylaxis in immediate peri-operative period.</li><li>\u2022 Antibiotics are now the most common cause of anaphylaxis in immediate peri-operative period.</li><li>\u2022 Antibiotics > Muscle relaxants are most common cause of anaphylaxis during anesthesia. Among muscle relaxants, Succinylcholine induces mast cell degranulation by crosslinking IgE receptors on mast cells . Succinylcholine is more likely to cause anaphylaxis than nondepolarizing muscle relaxants . Anaphylaxis may develop even on the first exposure to a muscle relaxant since they may already be sensitized to quaternary ammonium compounds present in products of daily use . Neostigmine & Morphine also can cause anaphylaxis .</li><li>\u2022 Antibiotics > Muscle relaxants are most common cause of anaphylaxis during anesthesia.</li><li>\u2022 most common cause</li><li>\u2022 anaphylaxis</li><li>\u2022 Among muscle relaxants, Succinylcholine induces mast cell degranulation by crosslinking IgE receptors on mast cells .</li><li>\u2022 Succinylcholine induces</li><li>\u2022 mast cell degranulation</li><li>\u2022 crosslinking IgE receptors</li><li>\u2022 mast cells</li><li>\u2022 Succinylcholine is more likely to cause anaphylaxis than nondepolarizing muscle relaxants .</li><li>\u2022 cause anaphylaxis</li><li>\u2022 nondepolarizing muscle relaxants</li><li>\u2022 Anaphylaxis may develop even on the first exposure to a muscle relaxant since they may already be sensitized to quaternary ammonium compounds present in products of daily use .</li><li>\u2022 develop</li><li>\u2022 first exposure</li><li>\u2022 muscle relaxant</li><li>\u2022 already</li><li>\u2022 sensitized</li><li>\u2022 quaternary ammonium compounds</li><li>\u2022 products of daily use</li><li>\u2022 Neostigmine & Morphine also can cause anaphylaxis .</li><li>\u2022 Neostigmine & Morphine</li><li>\u2022 anaphylaxis</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 Antibiotics, particularly beta-lactams , are the most common cause of immediate perioperative anaphylaxis , followed by neuromuscular blockers due to the presence of ammonium ions which are allergenic .</li><li>\u27a4 beta-lactams</li><li>\u27a4 most common cause</li><li>\u27a4 immediate perioperative anaphylaxis</li><li>\u27a4 neuromuscular blockers</li><li>\u27a4 presence of ammonium ions</li><li>\u27a4 allergenic</li><li>\u27a4 Antibiotics>Neuromuscular Blockers> Chlorhexidine>Local Anaesthetic> Latex</li><li>\u27a4 Antibiotics>Neuromuscular Blockers> Chlorhexidine>Local Anaesthetic> Latex</li><li>\u27a4 Ref : https://resources.wfsahq.org/atotw/an-update-on-perioperative anaphylaxis/#:~:text=Risk%20factors%20for%20anaphylaxis%20include,lactam%20antibiotics)%2C%20and%20latex .</li><li>\u27a4 Ref :</li><li>\u27a4 https://resources.wfsahq.org/atotw/an-update-on-perioperative anaphylaxis/#:~:text=Risk%20factors%20for%20anaphylaxis%20include,lactam%20antibiotics)%2C%20and%20latex</li><li>\u27a4 .</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "8a50f0fa",
      "audio": ""
    },
    {
      "text": "Shortest acting non-depolarizing neuromuscular blocking agent is?",
      "options": [
        {
          "label": "A",
          "text": "Atracurium",
          "correct": false
        },
        {
          "label": "B",
          "text": "Mivacurium",
          "correct": true
        },
        {
          "label": "C",
          "text": "Suxamethonium",
          "correct": false
        },
        {
          "label": "D",
          "text": "Rapacuronium",
          "correct": false
        }
      ],
      "correct_answer": "B. Mivacurium",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/19/screenshot-2023-12-19-144536.jpg"
      ],
      "explanation": "<p><strong>Ans. B. Mivacurium</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Muscle Relaxants</li><li>\u2022 Muscle Relaxants</li><li>\u2022 Mivacurium is the only non-depolarizing blocker that is metabolized by plasma cholinesterase and is the shortest-acting muscle relaxant .</li><li>\u2022 only non-depolarizing blocker</li><li>\u2022 metabolized</li><li>\u2022 plasma cholinesterase</li><li>\u2022 shortest-acting muscle relaxant</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 Long Acting: Pancuronium, Pipecuronium</li><li>\u27a4 Intermediate Acting: Atracurium,Cisatracurium.Vecuronium,Rocuronium</li><li>\u27a4 Short acting: Mivacurium Ultra-short acting: Gantacurium</li><li>\u27a4 Ref : Morgan and Mikhail\u2019s clinical anesthesiology 7 th edition pg 366-406</li><li>\u27a4 Ref :</li><li>\u27a4 Morgan and Mikhail\u2019s clinical anesthesiology 7 th edition pg 366-406</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "7f8a3bf3",
      "audio": ""
    },
    {
      "text": "Choose the Correct Answer: Assertion: Atracurium can be safely given in renal failure patients Reason: Atracurium undergoes Hofmann elimination",
      "options": [
        {
          "label": "A",
          "text": "Both Assertion and Reasoning are independently true/correct and Reason is the correct explanation of the Assertion",
          "correct": true
        },
        {
          "label": "B",
          "text": "Both Assertion and Reasoning are independently true/correct and Reason is not the correct explanation of the Assertion",
          "correct": false
        },
        {
          "label": "C",
          "text": "Assertion is independently a true/correct statement, but the Reason is independently an incorrect/false statement.",
          "correct": false
        },
        {
          "label": "D",
          "text": "Assertion is independently a false/incorrect statement, but the Reason is independently a true/correct statement.",
          "correct": false
        }
      ],
      "correct_answer": "A. Both Assertion and Reasoning are independently true/correct and Reason is the correct explanation of the Assertion",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A. Both Assertion and Reasoning are independently true/correct and Reason is the correct explanation of the Assertion</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Atracurium is a non-depolarizing neuromuscular blocker which can be safely administered to patients with renal failure due to its unique metabolism , which includes Hofmann elimination .</li><li>\u2022 non-depolarizing neuromuscular blocker</li><li>\u2022 safely administered</li><li>\u2022 patients with renal failure</li><li>\u2022 unique metabolism</li><li>\u2022 includes Hofmann elimination</li><li>\u2022 Assertion : \"Atracurium can be safely given in renal failure patients\" is a true statement . Since atracurium is metabolized via Hofmann elimination , it does not rely on renal or hepatic pathways for its clearance , making it a safe choice for patients with renal impairment . Reason : \"Atracurium undergoes Hofmann elimination\" is also a true statement . Hofmann elimination is a chemical process that occurs at physiological pH and temperature , resulting in the drug's breakdown independently of organ function .</li><li>\u2022 Assertion : \"Atracurium can be safely given in renal failure patients\" is a true statement . Since atracurium is metabolized via Hofmann elimination , it does not rely on renal or hepatic pathways for its clearance , making it a safe choice for patients with renal impairment .</li><li>\u2022 Assertion</li><li>\u2022 true statement</li><li>\u2022 metabolized via Hofmann elimination</li><li>\u2022 does not rely</li><li>\u2022 renal or hepatic pathways</li><li>\u2022 clearance</li><li>\u2022 safe choice</li><li>\u2022 patients</li><li>\u2022 renal impairment</li><li>\u2022 Reason : \"Atracurium undergoes Hofmann elimination\" is also a true statement . Hofmann elimination is a chemical process that occurs at physiological pH and temperature , resulting in the drug's breakdown independently of organ function .</li><li>\u2022 Reason</li><li>\u2022 true statement</li><li>\u2022 Hofmann elimination</li><li>\u2022 chemical process</li><li>\u2022 physiological pH</li><li>\u2022 temperature</li><li>\u2022 drug's breakdown</li><li>\u2022 independently</li><li>\u2022 organ function</li><li>\u2022 Thus, the reason \"Atracurium undergoes Hofmann elimination\" is indeed the correct explanation for why atracurium can be safely administered in renal failure patients .</li><li>\u2022 correct explanation</li><li>\u2022 safely administered</li><li>\u2022 renal failure patients</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 Atracurium is suitable for use in patients with renal failure because it undergoes Hofmann elimination , a non-enzymatic process that allows for the drug's clearance without relying on kidney function .</li><li>\u27a4 suitable</li><li>\u27a4 patients with renal failure</li><li>\u27a4 undergoes Hofmann elimination</li><li>\u27a4 non-enzymatic process</li><li>\u27a4 allows</li><li>\u27a4 drug's clearance</li><li>\u27a4 without relying</li><li>\u27a4 kidney function</li><li>\u27a4 Ref : Morgan and Mikhail\u2019s clinical anesthesiology 7 th edition pg 394-396</li><li>\u27a4 Ref :</li><li>\u27a4 Morgan and Mikhail\u2019s clinical anesthesiology 7 th edition pg 394-396</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "47acb329",
      "audio": ""
    },
    {
      "text": "All are characteristics of Non depolarizing Neuromuscular Blocking agents except?",
      "options": [
        {
          "label": "A",
          "text": "Fade on Train of Four Stimulation",
          "correct": false
        },
        {
          "label": "B",
          "text": "Tetanic Stimulation is Followed by Post Tetanic Facilitation.",
          "correct": false
        },
        {
          "label": "C",
          "text": "Shows Fasciculation.",
          "correct": true
        },
        {
          "label": "D",
          "text": "Reversed by Neostigmine",
          "correct": false
        }
      ],
      "correct_answer": "C. Shows Fasciculation.",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. Shows fasciculation</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Fasciculations are seen with depolarizing neuromuscular blocker since they have agonistic effect on nicotinic cholinergic receptor.</li><li>\u2022 Fasciculations</li><li>\u2022 depolarizing neuromuscular blocker</li><li>\u2022 agonistic effect</li><li>\u2022 nicotinic cholinergic receptor.</li><li>\u2022 Let\u2019s evaluate other options:</li><li>\u2022 Option A . Fade on Train of Four Stimulation : Non-depolarizing agents show a characteristic fade on repetitive nerve stimulation like train-of-four (TOF) , which is not present with depolarizing agents in a phase I block .</li><li>\u2022 Option A</li><li>\u2022 Fade on Train of Four Stimulation</li><li>\u2022 Non-depolarizing agents</li><li>\u2022 characteristic fade</li><li>\u2022 repetitive nerve stimulation</li><li>\u2022 train-of-four (TOF)</li><li>\u2022 not present</li><li>\u2022 depolarizing agents</li><li>\u2022 phase I block</li><li>\u2022 Option B . Tetanic Stimulation is Followed by Post Tetanic Facilitation : After tetanic stimulation, there is an increased response to subsequent twitches , known as post-tetanic potentiation , which is seen with non-depolarizing blocks due to increased acetylcholine release .</li><li>\u2022 Option B</li><li>\u2022 Tetanic Stimulation is Followed by Post Tetanic Facilitation</li><li>\u2022 increased response</li><li>\u2022 subsequent twitches</li><li>\u2022 post-tetanic potentiation</li><li>\u2022 non-depolarizing blocks</li><li>\u2022 increased acetylcholine release</li><li>\u2022 Option D . Reversed by Neostigmine : Non-depolarizing blocks can be reversed by anticholinesterase drugs like neostigmine, which increase acetylcholine levels in the synaptic cleft , outcompeting the blocker for the receptor .</li><li>\u2022 Option D</li><li>\u2022 Reversed by Neostigmine</li><li>\u2022 Non-depolarizing blocks</li><li>\u2022 reversed</li><li>\u2022 anticholinesterase drugs</li><li>\u2022 increase acetylcholine levels</li><li>\u2022 synaptic cleft</li><li>\u2022 outcompeting the blocker</li><li>\u2022 receptor</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 Fasciculation is a feature of depolarizing neuromuscular blockers due to their agonistic effect on nicotinic acetylcholine receptors and is not characteristic of non-depolarizing neuromuscular blocking agents, which are marked by fade on TOF stimulation and can be reversed by neostigmine .</li><li>\u27a4 depolarizing neuromuscular blockers</li><li>\u27a4 agonistic effect</li><li>\u27a4 nicotinic acetylcholine receptors</li><li>\u27a4 not characteristic</li><li>\u27a4 marked by fade</li><li>\u27a4 TOF stimulation</li><li>\u27a4 reversed by neostigmine</li><li>\u27a4 A phase I depolarization block from succinylcholine does not exhibit fade during tetanus or train-of-four; neither does it demonstrate post tetanic potentiation.</li><li>\u27a4 A phase I depolarization block from succinylcholine does not exhibit fade during tetanus or train-of-four; neither does it demonstrate post tetanic potentiation.</li><li>\u27a4 Ref : Morgan and Mikhail\u2019s clinical anesthesiology 7 th edition pg 378</li><li>\u27a4 Ref :</li><li>\u27a4 Morgan and Mikhail\u2019s clinical anesthesiology 7 th edition pg 378</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "c537754e",
      "audio": ""
    },
    {
      "text": "Metabolite of which muscle relaxant can cause seizures?",
      "options": [
        {
          "label": "A",
          "text": "Pancuronium",
          "correct": false
        },
        {
          "label": "B",
          "text": "Mivacurium",
          "correct": false
        },
        {
          "label": "C",
          "text": "Rocuronium",
          "correct": false
        },
        {
          "label": "D",
          "text": "Atracurium",
          "correct": true
        }
      ],
      "correct_answer": "D. Atracurium",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D. Atracurium</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Laudanosine is a breakdown product of atracurium's Hofmann elimination which can cause seizures when accumulated . This is seen when atracurium is given in large doses or in hepatic/renal failure .</li><li>\u2022 Laudanosine</li><li>\u2022 breakdown product</li><li>\u2022 atracurium's Hofmann elimination</li><li>\u2022 cause seizures when accumulated</li><li>\u2022 atracurium</li><li>\u2022 large doses</li><li>\u2022 hepatic/renal failure</li><li>\u2022 Cisatracurium is a stereoisomer of atracurium , which produces lesser laudanosine than atracurium.</li><li>\u2022 stereoisomer</li><li>\u2022 atracurium</li><li>\u2022 produces lesser laudanosine</li><li>\u2022 Educational objective</li><li>\u2022 Educational objective</li><li>\u2022 Laudanosine is a breakdown product of atracurium's Hofmann elimination which can cause seizures when accumulated. This is seen when atracurium is given in large doses or in hepatic/ renal failure.</li><li>\u2022 Ref : Morgan and Mikhail\u2019s clinical anesthesiology 7 th edition pg 394</li><li>\u2022 Ref :</li><li>\u2022 Morgan and Mikhail\u2019s clinical anesthesiology 7 th edition pg 394</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "e340fb2d",
      "audio": ""
    },
    {
      "text": "Which of these non-depolarizing agents is a Benzylisoquinoline compound?",
      "options": [
        {
          "label": "A",
          "text": "Pancuronium",
          "correct": false
        },
        {
          "label": "B",
          "text": "\ufeff\ufeffAtracurium",
          "correct": true
        },
        {
          "label": "C",
          "text": "\ufeff\ufeff\ufeffVecuronium",
          "correct": false
        },
        {
          "label": "D",
          "text": "\ufeff\ufeff\ufeffRocuronium",
          "correct": false
        }
      ],
      "correct_answer": "B. \ufeff\ufeffAtracurium",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/19/picture121_JjL6IYs.jpg"
      ],
      "explanation": "<p><strong>Ans. B. Atracurium</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Ref : Morgan and Mikhail\u2019s clinical anesthesiology 7 th edition pg 388</li><li>\u2022 Ref :</li><li>\u2022 Morgan and Mikhail\u2019s clinical anesthesiology 7 th edition pg 388</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "0b1cc459",
      "audio": ""
    },
    {
      "text": "Which of these is the most cardio stable muscle relaxant?",
      "options": [
        {
          "label": "A",
          "text": "Pancuronium",
          "correct": false
        },
        {
          "label": "B",
          "text": "\ufeff\ufeffAtracurium",
          "correct": false
        },
        {
          "label": "C",
          "text": "\ufeff\ufeff\ufeffVecuronium",
          "correct": true
        },
        {
          "label": "D",
          "text": "\ufeff\ufeff\ufeffRocuronium",
          "correct": false
        }
      ],
      "correct_answer": "C. \ufeff\ufeff\ufeffVecuronium",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. Vecuronium</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A . Pancuronium : This non-depolarizing muscle relaxant can increase heart rate and blood pressure due to vagolytic effects ( inhibition of vagus nerve activity ), making it less cardio-stable .</li><li>\u2022 Option A</li><li>\u2022 Pancuronium</li><li>\u2022 non-depolarizing muscle relaxant</li><li>\u2022 increase heart rate</li><li>\u2022 blood pressure</li><li>\u2022 vagolytic effects</li><li>\u2022 inhibition of vagus nerve activity</li><li>\u2022 less cardio-stable</li><li>\u2022 Option B . Atracurium : While atracurium is a good choice for patients with renal or hepatic impairment due to Hoffman elimination , it can cause histamine release , which may lead to hypotension and tachycardia .</li><li>\u2022 Option B</li><li>\u2022 Atracurium</li><li>\u2022 good choice for patients</li><li>\u2022 renal or hepatic impairment</li><li>\u2022 Hoffman elimination</li><li>\u2022 histamine release</li><li>\u2022 lead to hypotension</li><li>\u2022 tachycardia</li><li>\u2022 Option D . Rocuronium : Rocuronium is similar to vecuronium in terms of cardiovascular stability , but it has a rapid onset of action . However, in higher doses , it may have slight vagolytic activity .</li><li>\u2022 Option D</li><li>\u2022 Rocuronium</li><li>\u2022 similar to vecuronium</li><li>\u2022 cardiovascular stability</li><li>\u2022 rapid onset of action</li><li>\u2022 higher doses</li><li>\u2022 may</li><li>\u2022 slight vagolytic activity</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 Vecuronium is considered the most cardio-stable muscle relaxant because it lacks the vagolytic activity of pancuronium and the histamine-releasing potential of atracurium , leading to fewer cardiovascular side effects .</li><li>\u27a4 most cardio-stable muscle relaxant</li><li>\u27a4 lacks the vagolytic activity of pancuronium</li><li>\u27a4 histamine-releasing potential</li><li>\u27a4 atracurium</li><li>\u27a4 leading to fewer cardiovascular side effects</li><li>\u27a4 Ref : Morgan and Mikhail\u2019s clinical anaesthesiology 7 th edition pg 40</li><li>\u27a4 Ref : Morgan and Mikhail\u2019s clinical anaesthesiology 7 th edition pg 40</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "efa186b8",
      "audio": ""
    },
    {
      "text": "A 40-year-old chronic alcoholic with cirrhosis and hepatocellular carcinoma is undergoing liver resection surgery. Ideal muscle relaxant for this case would be?",
      "options": [
        {
          "label": "A",
          "text": "Pancuronium",
          "correct": false
        },
        {
          "label": "B",
          "text": "\ufeff\ufeffAtracurium",
          "correct": true
        },
        {
          "label": "C",
          "text": "\ufeff\ufeff\ufeffVecuronium",
          "correct": false
        },
        {
          "label": "D",
          "text": "\ufeff\ufeff\ufeffRocuronium",
          "correct": false
        }
      ],
      "correct_answer": "B. \ufeff\ufeffAtracurium",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. Atracurium</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 In a patient with cirrhosis and hepatocellular carcinoma undergoing liver resection , the metabolism and clearance of drugs can be significantly impaired . The choice of muscle relaxant in such cases is crucial .</li><li>\u2022 cirrhosis</li><li>\u2022 hepatocellular carcinoma</li><li>\u2022 liver resection</li><li>\u2022 metabolism</li><li>\u2022 clearance of drugs</li><li>\u2022 significantly impaired</li><li>\u2022 choice of muscle</li><li>\u2022 relaxant</li><li>\u2022 crucial</li><li>\u2022 Atracurium and Cisatracurium undergo Hofmann elimination and thus are not dependent on liver function for their clearance.</li><li>\u2022 Atracurium</li><li>\u2022 Cisatracurium</li><li>\u2022 Hofmann elimination</li><li>\u2022 not dependent</li><li>\u2022 liver function</li><li>\u2022 clearance.</li><li>\u2022 Option A . Pancuronium : This muscle relaxant is largely eliminated by the kidneys , but it is also metabolized by the liver . In patients with liver impairment , its effects could be prolonged and unpredictable .</li><li>\u2022 Option A</li><li>\u2022 Pancuronium</li><li>\u2022 muscle relaxant</li><li>\u2022 largely eliminated</li><li>\u2022 kidneys</li><li>\u2022 metabolized by the liver</li><li>\u2022 liver impairment</li><li>\u2022 effects</li><li>\u2022 prolonged</li><li>\u2022 unpredictable</li><li>\u2022 Option C . Vecuronium : Vecuronium is primarily metabolized in the liver , and its clearance could be reduced in patients with liver dysfunction , leading to prolonged effects .</li><li>\u2022 Option C</li><li>\u2022 Vecuronium</li><li>\u2022 primarily metabolized</li><li>\u2022 liver</li><li>\u2022 clearance</li><li>\u2022 reduced in patients</li><li>\u2022 liver dysfunction</li><li>\u2022 leading to prolonged effects</li><li>\u2022 Option D . Rocuronium : Similar to vecuronium, rocuronium is also metabolized in the liver to a significant extent, and its use in liver impairment could result in prolonged neuromuscular blockade .</li><li>\u2022 Option D</li><li>\u2022 Rocuronium</li><li>\u2022 also metabolized in the liver</li><li>\u2022 use in liver impairment</li><li>\u2022 prolonged neuromuscular blockade</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Atracurium is the preferred muscle relaxant for patients with liver dysfunction , such as cirrhosis and hepatocellular carcinoma, due to its Hofmann elimination which is independent of liver function .</li><li>\u27a4 preferred muscle relaxant</li><li>\u27a4 patients with liver dysfunction</li><li>\u27a4 Hofmann elimination</li><li>\u27a4 independent of liver function</li><li>\u27a4 Ref : Morgan and Mikhail\u2019s clinical anesthesiology 7 th edition pg 394</li><li>\u27a4 Ref : Morgan and Mikhail\u2019s clinical anesthesiology 7 th edition pg 394</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "41a3bdfa",
      "audio": ""
    }
  ]
}